Company: IMCR
Filing Date: 2025-02-26
Form Type: 10-K
Source: 0001671927-25-000006
Chunk: 10

Company: Immunocore Holdings plc
Filing Date: 2025-02-26
Form: 10-K
Item: Item 8
Chunk 10
---
 after the end of the fiscal year ended December 31, 2024.

135

Table of Contents

Item 14.    Principal Accountant Fees and Services

The information required by this item is incorporated by reference to our Proxy Statement for our 2025 Annual General Meeting of Shareholders to be filed with the SEC within 120 days after the end of the fiscal year ended December 31, 2024.

PART IV

Item 15.    Exhibits and Financial Statement Schedules

Incorporation by ReferenceExhibitNumberDescriptionSchedule/FormFileNumberExhibitFiling Date3.1Articles of Association of Immunocore Holdings plc10-Q001-399923.1August 8, 20244.1Deposit Agreement20-F001-399922.2March 25, 20214.2Form of American Depositary Receipt (included in Exhibit 4.1)20-F001-399922.3March 25, 20214.3Description of Registered Securities20-F001-399922.4March 25, 20214.4Indenture, dated as of February 2, 2024, by and between the Company and U.S. Bank Trust Company, National Association, as Trustee.8-K001-399924.1February 2, 20244.5Form of Global Note, representing the Company’s 2.50% Convertible Senior Notes due 2030 (included as Exhibit A to the Indenture filed as Exhibit 4.1).8-K001-399924.2February 2, 202410.1Subscription Agreement between the Registrant and the Bill & Melinda Gates Foundation, dated February 3, 2021F-1/A333-2521664.3February 3, 202110.2Amended and Restated Global Access Commitments Agreement, dated as of March 2, 2020, between the Registrant and the Bill & Melinda Gates FoundationF-1333-25216610.11January 15, 202110.3†First Amendment to the Amended and Restated Global Access Commitments Agreement, dated as of February 3, 2021, between the Registrant and the Bill & Melinda Gates FoundationF-1/A333-25216610.12February 3, 202110.4Lease, dated as of March 28, 2017, between the Registrant and MEPC MILTON PARK NO